EIF4A1
| Official symbol: | EIF4A1 |
| Full name: | eukaryotic translation initiation factor 4A1 |
| Location: | 17p13.1 |
| Also known as: | DDX2A, EIF-4A, EIF4A |
| Entrez ID: | 1973 |
| Ensembl ID: | ENSG00000161960 |
| Summary: | |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.16 |
|
|
|
| Recurrently deleted in 1 cancer type(s) |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
| Total fusion occurrence: | 1 |
|
|
| Fusions detected in 1 cancer type(s) |
|
| |
|
|
|
| |
Overall
|
|
Tissue specific
|
| |
CRISPR: COMMON ESSENTIAL
RNAi: COMMON ESSENTIAL
|
|
|
| |
|
|
|
| Functional class: | Not specified |
| JensenLab PubMed score: | 196.70 (Percentile rank: 81.50%) |
| PubTator score: | 96.34 (Percentile rank: 77.14%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Discovery PrecedenceTargets with ligands; Targets with crystal structures with ligands |
| Tractability (antibody): | |
